L'antithrombine III = Antithrombin IIIMASSIGNON, D.Lyon pharmaceutique. 1985, Vol 36, Num 1, pp 5-11, issn 0024-7804Article

ANTITHROMBIN III AND HEPARIN.BARROWCLIFFE TW; JOHNSON EA; THOMAS D et al.1978; BRIT. MED. BULL.; G.B.; DA. 1978; VOL. 34; NO 2; PP. 143-150; BIBL. 1 P. 1/2Article

Antithrombin III. Wirkung, Bestimmung mit dem chromogenen Substrat Chromozym Th^® und Klinische Bedeutung = Antithrombine III. Signification clinique = Antithrombin III. Clinical significanceSCHEJA, J; TAUBERT, W; BRUSTER, H. T et al.Labor - Medizin (GIT-Verlag Giebeler). 1983, Vol 6, Num 5, pp 315-319, issn 0170-205XArticle

ANTITHROMBIN III IN RAT HEPATOCYTESLEON M; AIACH M; GUENNEC JY et al.1982; THROMBOSIS RESEARCH; ISSN 0049-3848; USA; DA. 1982; VOL. 28; NO 1; PP. 115-123; BIBL. 30 REF.Article

Biodistribution of covalent antithrombin-heparin complexesCHINDEMI, Paul A; KLEMENT, Petr; KONECNY, Filip et al.Thrombosis and haemostasis. 2006, Vol 95, Num 4, pp 629-636, issn 0340-6245, 8 p.Article

A NEW FAMILIAL VARIANT OF ANTITHROMBIN. III: ANTITHROMBINE III PARIS'WOLF M; BOYER C; LAVERGNE JM et al.1982; BR. J. HAEMATOL.; ISSN 0007-1048; GBR; DA. 1982; VOL. 51; NO 2; PP. 285-295; BIBL. 35 REF.Article

Antithrombin Cambridge, 384 Ala to Pro: a new variant identified using the polymerase chain reactionPERRY, D. J; HARPER, P. L; FAIRHAM, S et al.FEBS letters. 1989, Vol 254, Num 1-2, pp 174-176, issn 0014-5793, 3 p.Article

Antithrombin : Early prophecies and present challengesABILDGAARD, Ulrich.Thrombosis and haemostasis. 2007, Vol 98, Num 1, pp 97-104, issn 0340-6245, 8 p.Article

Dysfunctional antithrombin III in sick premature infantsANDREW, M; MASSICOTTE-NOLAN, P; MITCHELL, L et al.Pediatric research. 1985, Vol 19, Num 2, pp 237-239, issn 0031-3998Article

Thrombin Inhibitors from Different AnimalsTANAKA-AZEVEDO, A. M; MORAIS-ZANI, K; TORQUATO, R. J. S et al.Journal of Biomedicine and Biotechnology (Print). 2010, Vol 2010, issn 1110-7243, 641025.1-641025.9, 4Article

Molecular heterogeneity of inherited antithrombin III deficiencyPROCHOWNIK, E. V; ANTONARAKIS, S; BAUER, K. A et al.The New England journal of medicine. 1983, Vol 308, Num 26, pp 1549-1552, issn 0028-4793Article

Antithrombin Glasgow, 393 Arg to His: a P₁ reactive site variant with increased heparin affinity but no thrombin inhibitory activityOWEN, M. C; BERESFORD, C. H; CARRELL, R. W et al.FEBS letters. 1988, Vol 231, Num 2, pp 317-320, issn 0014-5793Article

ANTITHROMBIN III (AT III) PADUA₂: A "NEW" CONGENITAL ABNORMALITY WITH DEFECTIVE HEPARIN CO-FACTOR ACTIVITIES BUT NO THROMBOTIC DISEASEGIROLAMI A; FABRIS F; CAPPELLATO G et al.1983; BLUT; ISSN 0006-5242; DEU; DA. 1983; VOL. 47; NO 2; PP. 93-103; BIBL. 31 REF.Article

Crossed immunoelectrophoresis in the study of abnormal antithrombins. III: behaviour of at III trentoGIROLAMI, A; RUBETELLI, M; MARAFIOTTI, P et al.British journal of haematology. 1983, Vol 55, Num 3, pp 559-561, issn 0007-1048Article

PRODUCTION IN VITRO AND PROPERTIES OF A MODIFIED FORM OF BOVINE ANTITHROMBIN, CLEAVED AT THE ACTIVE SITE BY THROMBINBJORK I; FISH WW.1982; JOURNAL OF BIOLOGICAL CHEMISTRY; ISSN 0021-9258; USA; DA. 1982; VOL. 257; NO 16; PP. 9487-9493; BIBL. 50 REF.Article

PLATELET ANTITHROMBIN ACTIVITYCZAPEK EE; KWAAN HC.1980; THROMBOSIS RES.; GBR; DA. 1980; VOL. 18; NO 5; PP. 623-627; BIBL. 7 REF.Article

Investigation on recombinant hirudin via oral routeXIAODONG CEN; JIANQUAN NI; TAOCHAO TAN et al.Peptides (New York, NY. 1980). 2006, Vol 27, Num 4, pp 836-840, issn 0196-9781, 5 p.Article

Effects of antithrombin and heparin cofactor II levels on anticoagulation with intimatanTANAKA, Kenichi A; SZLAM, Fania; VINTEN-JOHANSEN, Jakob et al.Thrombosis and haemostasis. 2005, Vol 94, Num 4, pp 808-813, issn 0340-6245, 6 p.Article

DEFICITS CONSTITUTIONNELS ET ACQUIS EN ANTITHROMBINE III: A PROPOS DE DEUX OBSERVATIONSLAHARRAGUE P; CAUSSE B; BOUISSOU F et al.1980; REV. MED. TOULOUSE; FRA; DA. 1980; VOL. 16; NO 4; PP. 201-205; (4 P.); ABS. ENG; BIBL. 16 REF.Article

Antithrombin Affects Hemostatic Response to Recombinant Activated Factor VII in Factor VIII Deficient PlasmaSZLAM, Fania; TAKETOMI, Taro; SHEPPARD, Chelsea A et al.Anesthesia and analgesia. 2008, Vol 106, Num 3, pp 719-724, issn 0003-2999, 6 p.Article

Conformation of the pentasaccharide corresponding to the binding site of heparin to antithrombin-IIIRAGAZZI, M; FERRO, D. R; PERLY, B et al.Carbohydrate research. 1987, Vol 165, Num 1, pp C1-C5, issn 0008-6215Article

ANTITHROMBINE PLASMATIQUE ET SERIQUE: METHODOLOGIE ET APPLICATIONS CLINIQUESCONARD JACQUELINE.1981; ; FRA; DA. 1981; 207 P.-PL.; 30 CM; BIBL. 25 P.; TH.: SCI. PHARM./PARIS 5/1981/58Thesis

Antithrombins : their potential as antithrombotic agentsWEITZ, J. I; HIRSH, J.Annual review of medicine. 1992, Vol 43, pp 9-16, issn 0066-4219Article

An abnormal plasma antithrombin with no apparent affinity for heparinCHASSE, J. F; ESNARD, F; GUITTON, J. D et al.Thrombosis research. 1984, Vol 34, Num 4, pp 297-302, issn 0049-3848Article

The effect of dilution on plasma coagulation kinetics determined by thrombelastography is dependent on antithrombin activity and mode of activationNIELSEN, Vance G; LYERLY, Ralph T; GURLEY, William Q et al.Anesthesia and analgesia. 2004, Vol 99, Num 6, pp 1587-1592, issn 0003-2999, 6 p.Article